Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
REGENXBIO Expands Pipeline Using NAV Vectors to Deliver Therapeutic Antibodies for the Treatment of Hereditary Angioedema and Neurodegenerative Diseases
Thursday, July 25, 2019REGENXBIO Inc a leading clinicalstage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform today announced an expansion of its pipeline to include novel treatme...
Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China
Thursday, July 25, 2019Aucta Pharmaceuticals Inc Aucta a technology based company focusing on the development and commercialization of Branded Specialty Products today announced that the Company has entered into an exclusive license agreement the Agreement with Jiangsu Wan...
Opiant Pharmaceuticals Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose
Wednesday, July 24, 2019Opiant Pharmaceuticals Inc a specialty pharmaceutical company developing medicines for addictions and drug overdose today announced that it has signed an agreement with Sanofi to manufacture Opiants investigational agent OPNTOO drinabant for the trea...
Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay
Wednesday, July 24, 2019Uman Diagnostics now part of Quanterix and BioTechne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light NfL on the ProteinSimplebranded Ella immunoassay platform Under the ter...
Avalon GloboCare and GE Healthcare Announce Strategic Partnership to Accelerate Standardized Automation and Bio-production for Cellular Medicines
Tuesday, July 23, 2019Avalon GloboCare Corp a leading clinicalstage global developer of cellbased technologies and therapeutics today announced that they have established a strategic partnership with GE Healthcare The partnership will accelerate Avalons standardization a...
Innovation Pharmaceuticals Announces License Agreement with Alfasigma S.p.A. for the Development and Commercialization of Brilacidin
Tuesday, July 23, 2019Innovation Pharmaceuticals a clinical stage biopharmaceutical company is pleased to report that the Company has executed a license agreement with Alfasigma SpA Alfasigma to develop and commercialize locallyadministered Brilacidin eg foam enema gel on...
Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US
Monday, July 22, 2019Ascentage Pharma a globallyfocused clinicalstage biotechnology company engaged in developing novel therapies for cancers hepatitis B virus and agerelated diseases today announced that the company was notified
Janssen Seeks EMA Approval for Novel Subcutaneous Formulation of DARZALEX (daratumumab)
Saturday, July 20, 2019The Janssen Pharmaceutical Companies of Johnson Johnson today announced the submission of an extension application to the European Medicines Agency EMA for subcutaneous under the skin use of DARZALEX daratumumab for the treatment of patients with mu...
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Friday, July 19, 2019Mallinckrodt plc a global biopharmaceutical company and Silence Therapeutics plc a leader in the discovery development and delivery of novel RNA interference RNAi therapeutics for the treatment of serious diseases today announced a collaboration tha...
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
Friday, July 19, 2019Boehringer Ingelheim and Bridge Biotherapeutics Inc today announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge Biotherapeuticss autotaxin inhibitor BBT for patients with fibrosing intersti...
